Squarepoint’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-69,002	Closed	-$12.7M	–	3765
2021 Q2	$12.7M	Sell	69,002 -25,223	-27%	-$4.33M	0.09%	379
2021 Q1	$14.4M	Buy	94,225 +58,136	+161%	+$8.99M	0.13%	272
2020 Q4	$5.64M	Buy	+36,089	New	+$4.64M	0.05%	441
2020 Q3	–	Sell	-113,165	Closed	-$12.7M	–	3003
2020 Q2	$12.7M	Buy	113,165 +45,334	+67%	+$4.81M	0.21%	121
2020 Q1	$6.09M	Sell	67,831 -34,239	-34%	-$3.36M	0.16%	152
2019 Q4	$11M	Sell	102,070 -133,899	-57%	-$14.3M	0.07%	270
2019 Q3	$23.1M	Buy	235,969 +178,839	+313%	+$20.2M	0.21%	115
2019 Q2	$7.48M	Buy	+57,130	New	+$7.36M	0.07%	321
2019 Q1	–	Sell	-69,327	Closed	-$6.75M	–	2549
2018 Q4	$6.75M	Buy	69,327 +15,824	+30%	+$1.87M	0.08%	331
2018 Q3	$7.44M	Buy	53,503 +18,530	+53%	+$2.32M	0.09%	299
2018 Q2	$4.34M	Sell	34,973 -66,674	-66%	-$7.79M	0.06%	433
2018 Q1	$11.3M	Buy	+101,647	New	+$12.1M	0.18%	150
2017 Q4	–	Sell	-102,262	Closed	-$14.3M	–	2429
2017 Q3	$14.3M	Buy	+102,262	New	+$13.9M	0.28%	78
2017 Q2	–	Sell	-16,132	Closed	-$1.96M	–	1920
2017 Q1	$1.96M	Buy	+16,132	New	+$2.08M	0.06%	394
2016 Q3	–	Sell	-16,574	Closed	-$1.94M	–	1357
2016 Q2	$1.94M	Buy	16,574 +14,199	+598%	+$2.01M	0.12%	201
2016 Q1	$331K	Buy	+2,375	New	+$349K	0.03%	789
2015 Q1	–	Sell	-3,100	Closed	-$574K	–	506
2014 Q4	$574K	Buy	+3,100	New	+$574K	0.56%	59

Other funds holding ALXN